Gastro-oesophageal reflux disease

被引:0
作者
Ronnie Fass
Guy E. Boeckxstaens
Hashem El-Serag
Rachel Rosen
Daniel Sifrim
Michael F. Vaezi
机构
[1] Case Western Reserve University,The Esophageal and Swallowing Center, Division of Gastroenterology and Hepatology, MetroHealth Medical System
[2] University of Leuven,Translational Research Center for Gastrointestinal Disorders (TARGID)
[3] Baylor College of Medicine,Department of Medicine
[4] Harvard Medical School,Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital
[5] Queen Mary University of London,Wingate Institute of Neurogastroenterology, Royal London Hospital, Barts and The London School of Medicine and Dentistry
[6] Vanderbilt University Medical Center,Division of Gastroenterology, Hepatology, and Nutrition
来源
Nature Reviews Disease Primers | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Gastro-oesophageal reflux disease (GERD) is a common disorder in adults and children. The global prevalence of GERD is high and increasing. Non-erosive reflux disease is the most common phenotype of GERD. Heartburn and regurgitation are considered classic symptoms but GERD may present with various atypical and extra-oesophageal manifestations. The pathophysiology of GERD is multifactorial and different mechanisms may result in GERD symptoms, including gastric composition and motility, anti-reflux barrier, refluxate characteristics, clearance mechanisms, mucosal integrity and symptom perception. In clinical practice, the diagnosis of GERD is commonly established on the basis of response to anti-reflux treatment; however, a more accurate diagnosis requires testing that includes upper gastrointestinal tract endoscopy and reflux monitoring. New techniques and new reflux testing parameters help to better phenotype the condition. In children, the diagnosis of GERD is primarily based on history and physical examination and treatment vary with age. Treatment in adults includes a combination of lifestyle modifications with pharmacological, endoscopic or surgical intervention. In refractory GERD, optimization of proton-pump inhibitor treatment should be attempted before a series of diagnostic tests to assess the patient’s phenotype.
引用
收藏
相关论文
共 816 条
[1]  
Vakil N(2006)The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus Am. J. Gastroenterol. 101 1900-1920
[2]  
van Zanten SV(2020)Nocturnal gastroesophageal reflux disease (GERD) and sleep: an important relationship that is commonly overlooked J. Clin. Gastroenterol. 54 663-674
[3]  
Kahrilas P(2013)Chronic cough and gastroesophageal reflux disease: how do we establish a causal link? Chest 143 587-589
[4]  
Dent J(2015)Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay Expert Rev. Gastroenterol. Hepatol. 9 969-982
[5]  
Jones R(2011)Noncardiac chest pain: epidemiology, natural course and pathogenesis J. Neurogastroenterol. Motil. 17 110-123
[6]  
Shibli F(2007)Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD Digestion 75 41-47
[7]  
Skeans J(2016)Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries Eur. J. Gastroenterol. Hepatol. 28 455-462
[8]  
Yamasaki T(2006)Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community Am. J. Gastroenterol. 101 18-28
[9]  
Fass R(2003)Quality of life in a general adult population with gastroesophageal reflux symptoms and/or esophagitis. A report from the Kalixanda study Gastroenterology 124 A168-1909
[10]  
Vaezi MF(1998)When does heartburn become a disease Gastroenterology 114 G1166-5